Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Imiquimod 5%/Egcg 1% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the treatment or absorption of active ingredients in a gel-like consistency. It is a compounded medication used to treat conditions such as Actinic Keratosis, Basal Cell Carcinoma, Bowen's Disease, Squamous Cell Carcinoma, and Molluscum Contagiosum.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Imiquimod 5%/Egcg 1% Topical Gel is a specially compounded medication designed to treat a range of skin conditions. This unique formulation combines two active ingredients, Imiquimod at a concentration of 5% and EGCG at 1%. These two ingredients work synergistically to reduce inflammation and promote healing.
Imiquimod is a potent immune response modifier. It works by stimulating the body's immune system to fight certain skin diseases, reducing inflammation and promoting healing in the process. On the other hand, EGCG, or Epigallocatechin gallate, is a powerful antioxidant. It helps to mitigate oxidative stress and protect the skin from further damage, enhancing the overall effectiveness of the treatment.
The gel is applied directly to the affected area of the skin, typically twice daily or as directed by a healthcare provider. The duration of treatment varies depending on the severity of the condition being treated.
Imiquimod 5%/Egcg 1% Topical Gel is dispensed in a semisolid formulation through a pump mechanism. This design facilitates easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation allows for a smooth application and absorption process.
Common side effects of this medication include redness, itching, burning, and irritation at the site of application. However, these are typically mild and subside as the body adjusts to the medication. It is crucial to follow the instructions of your healthcare provider when using this medication to ensure its effectiveness and minimize potential side effects.
If you have any questions or concerns about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. We are committed to providing comprehensive information and support to all our patients.
Imiquimod 5%/Egcg 1% Topical Gel is a compounded formulation that combines two potent active ingredients, Imiquimod and EGCG, to treat a variety of skin conditions. Imiquimod, an immune response modifier, has been effectively used in the treatment of actinic keratosis, superficial basal cell carcinoma, and external genital warts. On the other hand, EGCG, a powerful antioxidant, has been utilized in the management of psoriasis, atopic dermatitis, and acne.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. It is recommended to apply the gel to the affected area twice daily, taking care not to exceed the recommended amount. It is important to avoid contact with the eyes, nose, and mouth. In case of accidental contact, rinse with water immediately. Sun exposure should also be avoided while using this product, as it may increase the risk of sunburn.
Healthcare providers should be aware that Imiquimod 5%/Egcg 1% Topical Gel may cause skin irritation, redness, and itching. If these side effects occur, patients are advised to discontinue the product and contact their healthcare provider. Additionally, patients should be monitored for signs of infection, as this product may increase the risk of infection.
If you have any questions or concerns about Imiquimod 5%/Egcg 1% Topical Gel, please do not hesitate to reach out for further information.
Imiquimod 5%/Egcg 1% Topical Gel is a compounded formulation that combines the therapeutic benefits of two active ingredients, Imiquimod and EGCG, to treat a variety of skin conditions. Imiquimod is an immune response modifier that stimulates the body's own immune system to combat infections and other skin conditions. On the other hand, EGCG is a potent antioxidant that aids in reducing inflammation and protecting the skin from damage.
This unique combination works synergistically to alleviate symptoms associated with skin conditions such as psoriasis, eczema, and actinic keratosis. When applied to the affected area, the gel helps to reduce inflammation, itching, and redness. It also aids in reducing the size of lesions and can help to prevent the spread of the condition.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. It should be applied to the affected area twice daily, and should be left on for 8-12 hours before being washed off. It is crucial to adhere to the instructions provided by your healthcare provider when using this medication.
While Imiquimod 5%/Egcg 1% Topical Gel is generally well tolerated, some individuals may experience side effects such as skin irritation, redness, or burning. If you experience any of these side effects, it is important to contact your healthcare provider immediately.
If you have any questions about Imiquimod 5%/Egcg 1% Topical Gel or its mechanism of action, please do not hesitate to reach out to us at Bayview Pharmacy.
Imiquimod 5%/Egcg 1% Topical Gel is a compounded formulation that has been extensively researched for its potential therapeutic applications in a range of skin conditions. This includes genital warts, herpes simplex virus, and human papillomavirus, where it has demonstrated efficacy. The topical gel has also been investigated for its potential use in the treatment of psoriasis, acne, and alopecia areata. Furthermore, it has been studied for its potential use in addressing skin infections caused by bacteria, fungi, and viruses. The gel's potential anti-inflammatory properties have also been explored in the context of skin conditions such as contact dermatitis and atopic dermatitis. For any queries regarding the potential use of Imiquimod 5%/Egcg 1% Topical Gel for these conditions, please feel free to contact us.
Imiquimod 5%/Egcg 1% Topical Gel is a compounded formulation that contains two active ingredients, Imiquimod and Egcg. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The gel has a semisolid, gel-like consistency that allows for targeted treatment or absorption of the active ingredients.
The gel is applied topically on the skin. It is dispensed through a pump mechanism, which facilitates easy and precise application.
The pump mechanism is designed to facilitate easy and precise application of the gel on the skin. It ensures that the right amount of gel is dispensed each time.
Imiquimod 5%/Egcg 1% Topical Gel is used for specific skin conditions as prescribed by a healthcare professional. It is important to consult with your healthcare provider to determine if this formulation is suitable for your condition.
The active ingredients in this gel are Imiquimod and Egcg. Imiquimod is an immune response modifier while Egcg is a type of catechin found in green tea.
The frequency of application should be determined by your healthcare provider based on your specific condition and response to treatment. Always follow the instructions provided by your healthcare provider or pharmacist.
If you miss a dose, apply it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Like all medications, Imiquimod 5%/Egcg 1% Topical Gel can cause side effects. Common side effects may include redness, swelling, itching, or irritation at the application site. If these persist or worsen, contact your healthcare provider immediately.
Before using other skincare products while using this gel, it is recommended to discuss with your healthcare provider or pharmacist. They can provide guidance on whether it is safe to use other products in conjunction with this gel.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
